This project is funded by:
Mushrooms have been used in Japanese and Chinese medicine for thousands of years, owing to their bioactive properties in humans (1). In recent years the pharmaceutical industry have been concentrating on developing natural bioactive substances into new potent pharmaceutical drugs. Therefore research into biologically active mushrooms is of great interest to the biomedical field (1).
Mushroom compounds have been linked to the treatment of many diseases including cancer (2), diabetes (3, 4), depression (5), immune disorders (6), sepsis, HIV and even malaria. Non-bioactive compounds from mushrooms have also been used in biomedical science as a novel drug delivery method to help carry bioactive drugs across biological membranes.
K Hughes & Co Limited have developed a novel and patented method for the extraction of “pure” mushroom compounds. In collaboration with Ulster University has K Hughes & Co Limited shown that their novel compounds have shown potent bioactive properties against a range of diseases.
The aim of this PhD project is to elucidate the bioactivity of a novel compound extracted from a rare mushroom, Isaria (Cordyceps) Sinclairii. This project will involve in vitro testing, to determine bioactivity of compound utilising cell culture, xCELLigence, flow cytometry and Radio ImmunoAssay (RIA). Subsequently, bioavailability will be ascertained in vivo involving mass spectrometry confirmation of compound and finally in vivo bioactivity confirmed in a disease state involving confocal imaging, IVIS imaging, Mass Spectrometry Imaging (MSI) and immune function testing.
This project will aim to discovery a potential new treatment for diabetes or cancer.
References:
1. Worthington J and Rashid S. The therapeutic potential of mushroom extract. Natural Products as future therapeutic agents. Old City Publishing, pp. 49-72.
2. Sullivan E, Smith JE and Rowan NJ. Medicinal Mushrooms and Cancer Therapy: translating a traditional practice into Western medicine. Perspectives in Biology and Medicine 2006; 49(2):159-170
3. Lo HC and Wasser SP. Medicinal mushrooms for glycemic control in diabetes mellitus: history, current status, future perspectives, and unsolved problems (review). International Journal of Medicinal Mushrooms 2011; 13(5):401-26
4. Gray AM and Flatt PR. Insulin-releasing and insulin-like activity of Agaricus campestris (mushroom). The Journal of Endocrinology 1998 May; 157(2):259-66 5
5. Song J, Wang X, Huang Y, Qu Y, Wang D and Meng Z. Antidepressant-like effects of Marasmius androsaceus metabolic exopolysaccharides on chronic unpredictable mild stress-induced rat model. Molecular medicine reports 2017 Oct; 16(4):5043-5049
6. Guggenheim AG, Wright KM and Zwickey HL. Immune Modulation From Five Major Mushrooms: Application to Integrative Oncology. Integrative Medicine 2014 Feb; 13(1):32-44
Applicants should hold, or expect to obtain, a First or Upper Second Class Honours Degree in a subject relevant to the proposed area of study.
We may also consider applications from those who hold equivalent qualifications, for example, a Lower Second Class Honours Degree plus a Master’s Degree with Distinction.
In exceptional circumstances, the University may consider a portfolio of evidence from applicants who have appropriate professional experience which is equivalent to the learning outcomes of an Honours degree in lieu of academic qualifications.
If the University receives a large number of applicants for the project, the following desirable criteria may be applied to shortlist applicants for interview.
This project is funded by:
The University offers the following levels of support:
The scholarship will cover tuition fees at the Home rate and a maintenance allowance of £19,000 (tbc) per annum for three years (subject to satisfactory academic performance).
This scholarship also comes with £900 per annum for three years as a research training support grant (RTSG) allocation to help support the PhD researcher.
Due consideration should be given to financing your studies. Further information on cost of living
Submission deadline
Monday 18 February 2019
12:00AM
Interview Date
w/c 11, 18 and 25th March 2019
Preferred student start date
September 2019
Telephone
Contact by phone
Email
Contact by email